CMBL anticorps (AA 2-245)
-
- Antigène Voir toutes CMBL Anticorps
- CMBL (Carboxymethylenebutenolidase Homolog (CMBL))
-
Épitope
- AA 2-245
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CMBL est non-conjugé
- Application
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain, Souris
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Carboxymethylenebutenolidase homolog protein (2-245AA)
- Isotype
- IgG
-
-
- Indications d'application
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CMBL (Carboxymethylenebutenolidase Homolog (CMBL))
- Autre désignation
- CMBL (CMBL Produits)
- Synonymes
- anticorps JS-1, anticorps RGD1306952, anticorps 2310016A09Rik, anticorps carboxymethylenebutenolidase homolog, anticorps carboxymethylenebutenolidase-like (Pseudomonas), anticorps CMBL, anticorps Cmbl
- Sujet
-
Background: Cysteine hydrolase. Can convert the prodrug olmesartan medoxomil into its pharmacologically active metabolite olmerstatan, an angiotensin receptor blocker, in liver and intestine. May also activate beta-lactam antibiotics faropenem medoxomil and lenampicillin.
Aliases: Carboxymethylenebutenolidase homolog (Pseudomonas) antibody, Carboxymethylenebutenolidase homolog antibody, cmbl antibody, CMBL_HUMAN antibody, FLJ23617 antibody
- UniProt
- Q96DG6
-